The landscape of dementia analysis has progressed dramatically with the appearance of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent checks which can detect Alzheimer's pathology several years before signs emerge. When these technological improvements symbolize exceptional development in knowledge neurodegener